Why did pexelizumab fail to benefit acute myocardial infarction (STEMI) patients undergoing primary PCI? Insights into the role of inflammation and immunity and the complement inhibitor pexelizumab

Journal Article (Journal)

Full Text

Duke Authors

Cited Authors

  • Theroux, P; Neumann, FJ; Hamm, CW; Mahaffey, KW; Hochman, JS; James, S; Montalescot, G; Stebbins, AL; Armstrong, PW; Granger, CB

Published Date

  • September 1, 2007

Published In

Volume / Issue

  • 28 /

Start / End Page

  • 384 - 385

Published By


  • 2

International Standard Serial Number (ISSN)

  • 0195-668X


  • English